N/A
Completed N=102
COach2Quit TRIAL: Assessing a Prototype Personal Carbon Monoxide Monitor for Smoking Cessation
Source: ClinicalTrials.gov NCT03142932 ↗Enrolled (actual)
102
Serious AEs
0.0%
Results posted
Nov 2018
Primary outcomePrimary: Smoking Status Using a Point of Care Test for Measuring Carbon Monoxide (CO) — 22.0; 23.0 parts per million
Summary
The objective of this study is to conduct a randomized controlled trial to determine whether the use of the COach2Quit application (app) reduces smoking more than brief advice for smoking cessation. The investigators hypothesize that real time biomarker feedback and messaging support from the COach2Quit app will lead to greater smoking cessation rates than brief anti-smoking advice alone. If effective, the COach2Quit app could be an easily accessible and cost-effective tool to help smokers quit. The findings from this trial could have implications for the delivery of future outpatient smoking cessation programs.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Smoking Status Using a Point of Care Test for Measuring Carbon Monoxide (CO) |
18.5; 19.5 | — |
| PRIMARY Number of Participants With Color Change for Urine Test for Measuring Cotinine |
1; 1; 6; 2; 11; 10 | — |
| SECONDARY Reasons for Quitting Scale |
2.6; 2.6 | — |
Eligibility Criteria
Inclusion Criteria
- ≥18 years of age
- current, daily smokers
- agree to participate and anticipate to be living in Baltimore for at least 2 months
- own a phone that is compatible with the app
- be willing to set at baseline assessment a quit date within 2 weeks
Exclusion Criteria
- are suffering from any unstable medical condition precluding the use of the CO monitor (e.g. severe COPD)
- are currently using smokeless tobacco including e-cigarettes
- are currently using nicotine replacement therapy or other smoking cessation treatment
- are pregnant, determined by participant self-report
- have a negative baseline result on both urine cotinine AND CO monitor
Data sourced from ClinicalTrials.gov (NCT03142932). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.